Treat first! Shade says…

Slides:



Advertisements
Similar presentations
HOUSING IS HEALTH CARE MARGARET FLANAGAN, LGSW DISABILITY AND CASE MANAGEMENT COORDINATOR Health Care for the Homeless (HCH)
Advertisements

Using medicaid with HUD’s Homeless Assistance Programs
William F. Ryan Community Health Center 110 West 97 th street New York, NY Eishelle Tillery, MSW Nancy Andino, LCSW www. Ryancenter.org.
LINCS : Using Harm Reduction while working together with HIV+ patients in San Francisco Department of Public Health November 17, 2012 Harm Reduction Coalition.
SFGH- Department of Psychiatry Emergency Department Case Management Program (EDCM) September 24, 2012 Kathy O’Brien, LCSW Program Coordinator
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
Deizel Sarte, Chief Operations OfficerJune 24, 2015 ACA-PCMH-TBC and The Medical Assistant-Health Coach Initiative.
Clinical Management of the HIV Infected Transplant Recipient: How to Balance the Needs of the Patient and the Health Care Team.
PROJECT INSPIRE NYC Hep C Taskforce Meeting May 20,
Hospital Discharge of Homeless Persons in Chicago
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
2014 HIV.STD.TB.Viral Hepatitis Symposium. Program Staff Lindsey VanderBusch – Program Manager Sarah.
OVERVIEW OF PROJECT INSPIRE NYC Marie Bresnahan, MPH Project Director May 20,
PROJECT IN-CARE Chicago’s Positive Charge Project Roman Buenrostro, AIDS Foundation of Chicago Sunday July 22, 2012.
Bringing Hepatitis C Treatment into the Medical Home A Pilot Program for Drug Users Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission.
California Department of Public Health Office of AIDS HIV CARE and PREVENTION 2009: You Need to Know.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Adult Hepatitis A and B Vaccination in Traditional and Non-Traditional Sites, North Carolina Beth Rowe-West, Head Immunization Branch Division of Public.
The Reduction of Emergency Room Visits for Non- Emergent Health Concerns in Bakersfield, California Mariah Walton, MPH Public Health Advisor Office for.
Eliminating Barriers to Increase Uptake of PrEP in a Community- Based Clinic in San Francisco Presenting Author: Pierre-Cédric Crouch, PhD, ANP-BC, ACRN,
Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.
Effective and Collaborative Communication with KPD
Nurse Managed 12 week Latent Tuberculosis Infection Treatment
Hepatitis C Virus Program in Chicago
State Office of AIDS Update
Medical Wellness Program
Home Based Palliative Care
Addressing the Intersection of Substance Abuse and Viral Hepatitis
A Smile Makes all the Difference
Integrating Hepatitis into the World of Community Planning
INCLUSION: Public Health interventions in substance misuse Faculty of public health conference, 2017 Welcome.
Encampment Resolution Team San Francisco’s Approach to Homeless Encampments Jeff Jeff Kositsky Director, Department of Homelessness and Supportive Housing.
2003 National Hepatitis Coordinator’s Conference
Current harm reduction program at outreach
Marie P. Bresnahan, MPH, Mary M
Hospital Discharge of Homeless Persons in Chicago
Weaving a Strong Safety Net: Oral Health Care Access
FUTURE RECOMMENDATIONS
Clinical outcome after SVR: Veterans Affairs
Cherokee Nation Health Services HCV Elimination Program
Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,
Rowe, KA1, Tesoriero, JM1, Davis, SJ1, Heavner, KK1, Rothman, J2,
New York State Hepatitis C Continuity Program
Building a Data Driven HCV Screening and Linkage-to-Care Program
Community Care Teams Carl Schiessl, Director, Regulatory Advocacy
Lesson 4: Preventing HCV Reinfection
Establishing a Pharmacy Managed HCV Service
Medically Indigent (WELL) Screening and Verification Pilot
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
2017 State of C.O.R.E. performance measures.
Community Intervention Strategies
Starting an HCV Clinic Authored and Presented by: LCDR Jonathan Owen, PharmD Neelam Gazarian, MS, PharmD Quentin N. Burdick Memorial Health Care Facility.
Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.
San Jose Unified School District: Putting Health Care Back Into Schools Demonstration Project funded by Lucile Packard Children’s Hospital and Lucile Packard.
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
The HRSA/SPNS Hepatitis C Treatment Expansion Initiative: Project Summary Webinar for Demonstration Clinics.
Diabetes Management a Patient Centered Collaborative Care Model
Increasing Access to Tele-psychiatry in Rural and Frontier Colorado
Progress in Facilitating National HCV Prevention
Optum’s Role in Mycare Ohio
Caring for the Expanding Patient Population:  Treating the Recently Incarcerated
Primary Care Treatment of Hepatitis C
Lesson 3: Treatment as Prevention
Primary and acute care to reduce morbidity and pain
SAMPLE ONLY Dominion Health Center: Excellence in Medicaid Managed Care (or another defining message) Dominion Health Center is a community health center.
SAMPLE ONLY Dominion Health Center: Your Community Partner for Excellent Care (or another defining message) Dominion Health Center is a community health.
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
SAMPLE ONLY Dominion Health Center: Your Community Partner for Excellent Care (or another defining message) Dominion Health Center is a community health.
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

Treat first! Shade says… Establishing Access to Hepatitis C Treatment in a Nurse Practitioner-led Community-Based Syringe Access Center in San Francisco Pauli Gray (He/Him/His) Sr SAS HCV Wellness Coordinator Pierre-Cédric Crouch, PhD, ANP-BC, ACRN Director of Nursing Magnet @Strut

Disclosures We have no disclosures San Francisco and California have privilege which makes this work easier than other places San Francisco AIDS Foudation

1 2 Objectives Why we do this Walk through Hep C Health Program San Francisco AIDS Foudation

TREAT FIRST! 5 PRONGS: TREAT at Syringe Access sites SHADE SAYS... TREAT FIRST! 5 PRONGS: TREAT at Syringe Access sites NO HOOPS to jump through OFFER HCV MED STORAGE SUPPORT/WRAP-AROUND SERVICES SECONDARY GOALS

TAKEAWAYS Each time we partner to cure a single case of PWID Hep C, we are helping prevent 25 others from being infected We have the unique opportunity of curing the deadliest communicable disease and the honor of facilitating a huge change and providing hope in people’s lives.

San Francisco AIDS Foundation Harm Reduction Center Mobile Testing Unit Magnet at Strut Main Downtown Office SAN FRANCISCO AIDS FOUNDATION

Hepatitis C Program End Hep C SF Hep C Treatment Priority Communities Out of care Expanded Magnet HCV Testing Priority Communities IDU, Gay/MSM, Kink/Blood, HIV Positive Hep C Navigation and Treatment Support Tx Breakfast Medication Storage End Hep C SF San Francisco AIDS Foundation

Harm Reduction Center Visit Schedule Screening H&P: Focus on Cirrhosis Labs: CBC, LFTs, PT- INR, HCV RNA, HCV GT HCV Counseling Prior Authorization Initiation Within 1-2 weeks of screening Adherence Counseling Week 4 HCV Counseling CBC, LFTs, HCV RNA Week 8, 12 HCV Reinfection Counseling SVR12 HCV Reinfection Counseling Labs: HCV RNA Ongoing treatment breakfast, medication storage, & HCV counseling by navigators San Francisco AIDS Foundation

Hep C Treatment Program Eligibility Generally Healthy over age 18 Exclude decompensated cirrhosis Prefer monoinfected Hep C May work with HIV coinfected with PCP Do not bill professional fees Allows us to accept most insurance for labs and meds No need to change medical home Unable to treat Kaiser or VA clients Able to treat uninsured and undocumented clients Abbvie and Gilead Patient Assistance San Francisco AIDS Foundation

Outcomes Age 26-69 (43.8) Gender Cis-male 34 Cis-female 8 Transfemme 1 Clients Screened 86 Clients Initiating treatment 61 Clients Completing Treatment 44 (14 active) Clients Achieving SVR12 21/23 (91%) Clients not initiating 6-Cleared Hep C 2-Medically complex 1-Enrolled in Research 3-Did not return to initiate 3-other Clients with Incomplete Treatment 3 Clients Not Achieving SVR12 1 Reinfected 1 Adherence Cross-sectional data from November 9, 2018 San Francisco AIDS Foundation Table 1 Demographics Age 26-69 (43.8) Gender Cis-male 34 Cis-female 8 Transfemme 1 Transmasculine Gender Non-conforming 2 Race/Ethnicity Latinx White 30 AA/Black 9 Asian/API Multiple 4 Table 1 Demographics Age 26-69 (43.8) Gender Cis-male 34 Cis-female 8 Transfemme 1 Transmasculine Gender Non-conforming 2 Race/Ethnicity Latinx White 30 AA/Black 9 Asian/API Multiple 4

Demographics Age Range Mean 26-69 (43.8) Gender Cis-male 34 (76%) 24-69 (42.3) Gender Cis-male 67 (78%) Cis-female 15 (17%) Transfemme 1 (1%) Transmasculine 0 (0%) Gender Non-Conforming 2 (2%) Race/Ethnicity Latinx/o/a 6 (7%) White 58 (67%) AA/Black 17 (20%) Asian/PI Native American Multiple 3 (4%) Table 1 Demographics Age Range Mean 26-69 (43.8) Gender Cis-male 34 (76%) Cis-female 8 (18%) Transfemme 1 (2%) Transmasculine 0 (0%) Gender Non-conforming 2 (4%) Race/Ethnicity Latinx White 30 (68%) AA/Black 9 (20%) Asian/API Native American Multiple 4 (9%) Table 1 Demographics Age Range Mean 26-69 (43.8) Gender Cis-male 34 (76%) Cis-female 8 (18%) Transfemme 1 (2%) Transmasculine 0 (0%) Gender Non-conforming 2 (4%) Race/Ethnicity Latinx White 30 (68%) AA/Black 9 (20%) Asian/API Native American Multiple 4 (9%) Table 1 Demographics Age Range Mean 26-69 (43.8) Gender Cis-male 34 (76%) Cis-female 8 (18%) Transfemme 1 (2%) Transmasculine 0 (0%) Gender Non-conforming 2 (4%) Race/Ethnicity Latinx White 30 (68%) AA/Black 9 (20%) Asian/API Native American Multiple 4 (9%) San Francisco AIDS Foundation

Demographics Primary Care Provider Barrier No provider in last year 58 (67%) Provider with Cultural Barrier (problem with their provider) 10 (12%) Clinic with Structural Barrier (problem with how clinic is set up) 5 (6%) Prefer treatment at SFAF despite easy access elsewhere 13 (15%) Housing Marginally housed (SRO) 11 (13%) Homeless 44 (51%) Stable Housing 31 (36%) Substance Use Current Use 77 (90%) Prior Use 6 (7%) Never used 3 (4%) San Francisco AIDS Foundation

Demographics AST to Platelet Ratio >1 (potential liver damage) 14 (18%) <1 (less likely to have liver damage) 62 (82%) Weeks of Treatment 8 weeks 58 (78%) 12 weeks 15 (22%) San Francisco AIDS Foundation

Discussion People living with active substance use can successfully be cured of Hepatitis C. Differentiated Service Delivery of Hepatitis C treatment in a Syringe Access Service can reach communities who traditional healthcare settings have struggled to reach. San Francisco AIDS Foundation

Facilitators Facilitators A ”treat first” approach allows for clients to focus on Hepatitis C treatment Newer 8 week treatments facilitate cures Expanded Nursing Scopes of Practice No billing of professional fees Reduced barriers for Medi-Cal/Medicaid coverage San Francisco AIDS Foundation

Barriers Barriers Lack of Nurse Practitioner Autonomy in California Blood Specimen Collection Microtainers, Newer technologies use capillary sticks Funding to expand program San Francisco AIDS Foundation

Thank You! To all the clients who put their trust in our team. All SFAF staff and volunteers and the San Francisco community who support our work. Protocols: https://tinyurl.com/hepcSFAF San Francisco AIDS Foundation

TREAT FIRST, SAVE LIVES SPREAD THE WORD

Contact Info Pauli Gray pgray@sfaf.org Pierre-Cedric Crouch pcrouch@sfaf.org Janessa Broussard jbroussard@sfaf.org San Francisco AIDS Foundation